PMDA drug package insert
ロピバカイン塩酸塩0.75%注75mg/10mL「テルモ」
PMDA Prescription drug · テルモ株式会社 · package insert Nov 12, 2024
Key facts
| Brand names | ロピバカイン塩酸塩0.75%注75mg/10mL「テルモ」, ロピバカイン塩酸塩0.75%注150mg/20mL「テルモ」 |
|---|---|
| Nonproprietary names | ロピバカイン塩酸塩水和物 |
| Companies | 製造販売元／テルモ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 長時間作用性局所麻酔剤 |
| Therapeutic category codes | 871214 |
| YJ codes | 1214405A3036, 1214405A4032 |
| Approval numbers | 30600AMX00218, 30600AMX00228 |
| Package insert edition | 第1版 |
| Package insert date | Nov 12, 2024 |
| PMDA document key | 470034_1214405A3036_1 |
| PMDA company code | 470034 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: